46.51USD-0.62%Mkt Cap: 2.70B $P/E: —1d ago
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. It offers Qelbree…
Industry Peers
Drug Manufacturers - Specialty & Genericvs Drug Manufacturers - Specialty & Generic
P/B
Avg
1M Perf
Avg
$69.40BUSDP/E 25.2
$23.00BUSDP/E 20.0
$18.49BUSD
$16.95BUSDP/E 26.0
$15.35BUSDP/E 175.0
$15.16BUSDP/E 31.8
$12.29BUSD
$8.30BUSDP/E 21.1
$8.02BUSD
$7.22BUSDP/E 26.5
$7.09BUSDP/E 469.0
$5.52BUSDP/E 46.8
$3.54BUSDP/E 18.4
$3.48BUSDP/E 11.1
$3.22BUSDP/E 22.4
$2.66BUSDP/E 59.3
$2.54BUSDP/E 17.6
$2.54BUSD
$2.24BUSDP/E 12.1
$1.92BUSDP/E 19.4
$2.00BUSD
$1.77BUSD
$1.88BUSDP/E 21.2
$1.90BUSD
$1.56BUSDP/E 18.4
$1.58BUSD
$1.37BUSDP/E 113.1
$1.27BUSDP/E 13.5
$1.13BUSDP/E 35.6
$1.17BUSDP/E 17.6
$1.23BUSD
$1.09BUSD
$1.07BUSDP/E Infinity
$964.80MUSD
$998.26MUSDP/E 195.2
$991.60MUSD
$912.76MUSDP/E 39.9
$895.85MUSDP/E 14.4
$889.80MUSDP/E 12.2
$814.31MUSDP/E Infinity
$693.02MUSDP/E 6.8
$704.28MUSDP/E 164.2
$522.76MUSDP/E 14.7
$521.87MUSD
$488.71MUSD
$457.03MUSD
$450.66MUSD
$432.38MUSD
$323.33MUSD
$317.55MUSDP/E 43.3
$312.68MUSD
$342.71MUSD
$305.81MUSD
$304.53MUSD
$288.10MUSDP/E 51.7
$308.25MUSDP/E 9.9
$294.94MUSDP/E 15.2
$268.98MUSDP/E 9.7
$250.67MUSDP/E 47.7
$261.08MUSDP/E 13.0
$239.98MUSDP/E 53.8
$196.92MUSD
$194.94MUSD
$194.66MUSD
$182.70MUSDP/E 8.8
$178.18MUSD
$147.49MUSDP/E 18.8
$151.86MUSD
$138.58MUSD
$148.14MUSD
$125.08MUSD
$119.66MUSDP/E 18.6
$100.44MUSD
$97.09MUSD
$85.39MUSDP/E 12.3
$80.64MUSD
$72.08MUSD
$66.94MUSDP/E 56.4
$67.12MUSD
$64.16MUSD
$66.36MUSDP/E 22.8
$55.72MUSD
$60.45MUSD
$48.97MUSD
$53.46MUSD
$50.41MUSD
$42.17MUSD
$43.54MUSD
$35.03MUSDP/E Infinity
$32.51MUSD
$29.51MUSD
$25.58MUSDP/E 221.0
$23.08MUSD
$23.13MUSD
$21.73MUSD
$21.66MUSD
$18.56MUSD
$16.34MUSD
$14.36MUSDP/E 17.5
$13.58MUSD
$12.11MUSD
$11.27MUSD
$11.45MUSD
$9.80MUSD
$8.90MUSD
$7.07MUSDP/E 0.3
$6.32MUSD
$5.89MUSD
$4.95MUSDP/E 4.0
$5.64MUSDP/E Infinity
$3.29MUSDP/E 1.4
$2.15MUSD
$1.93MUSD
$1.90MUSDP/E 32.5
$1.54MUSD
$668.8KUSD
$216.1KUSDP/E 0.0
$350USD
Indicators:|
Key Statistics
Company
Market Cap2.70B $
Enterprise Value2.36B $
Revenue (TTM)776.83M $
Gross Profit644.39M $
Net Income (TTM)-38.55M $
Revenue/Share13.65 USD
Last Price46.51 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees778
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINUS8684591089
Valuation
P/E (Trailing)—
P/E (Forward)10.71
PEG—
EV/EBITDA19.22
EV/Revenue3.03
P/S3.47
P/B2.52
EPS (TTM)-0.51
EPS (Forward)4.34
52W Range
31.1654% of range59.68
52W High59.68 USD
52W Low31.16 USD
Profitability
Gross Margin89.63%
Oper. Margin-3.58%
EBITDA Margin15.79%
Profit Margin-5.36%
ROE-3.63%
ROA-2.65%
Growth
Revenue Growth38.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF47.33M $
CapEx (TTM)1.34M $
FCF Margin17.07%
FCF Yield4.91%
Net Debt-343.34M $
Net Debt/EBITDA-2.80
Balance Sheet
Debt/Equity0.04
Current Ratio1.96
Quick Ratio1.51
Book Value/Sh18.48 USD
Cash/Share6.620 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)62.83 USD
Upside (mean)+35.1%
Target Range55.00 USD – 66.00 USD
$55.00+35.1% to mean$66.00
# Analysts6
Ownership
Shares Out.58.04M
Float52.12M
Insiders4.46%
Institutions103.90%
Short Interest
Short Ratio10.3d
Short % Float12.92%
Short % Out.10.52%
Shares Short6.10M
Short (prev mo.)4.73M
Technical
SMA 5047.50 (-2.1%)
SMA 20048.98 (-5.1%)
Beta0.54
S&P 52W Chg20.05%
Avg Vol (30d)620.21K
Avg Vol (10d)1.01M
Technical Indicators
RSI (14)53.7
MACD-0.3672
MACD Signal-0.8227
MACD Hist.+0.4555
BB Upper46.81 USD
BB Middle44.86 USD
BB Lower42.90 USD
BB Width8.72%
ATR (14)1.427 USD
Vol Ratio (20d)0.96x